Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran.
Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Eur J Pharm Sci. 2022 Nov 1;178:106284. doi: 10.1016/j.ejps.2022.106284. Epub 2022 Aug 26.
Abdominal aortic aneurysm (AAA) is a prevalent condition which causes progressive growth and rupture of aortic wall with a high death rate. Several studies have found that treatment with statins may decrease the progress of AAA and the risk of rupture by suppressing the inflammatory mediators, decreasing oxidative stress, and inhibiting mechanisms involved in extracellular matrix (ECM) degradation. Moreover, some studies have reported that prehospital therapy with statins can decrease mortality after surgery. The novelty of this paper is that different studies including those performed in humans and animals were reviewed and the potential mechanisms by which statins can have an effect on AAA were summarized. Overall, the evidence suggested an association between treatment with statins and improvement of AAA.
腹主动脉瘤(AAA)是一种常见病症,可导致主动脉壁进行性扩张和破裂,死亡率很高。多项研究发现,他汀类药物治疗可通过抑制炎症介质、减少氧化应激以及抑制细胞外基质(ECM)降解机制,来减缓 AAA 的进展和破裂风险。此外,一些研究报告称,他汀类药物的院前治疗可降低手术后的死亡率。本文的新颖之处在于,对包括人类和动物在内的不同研究进行了综述,并总结了他汀类药物对 AAA 产生作用的潜在机制。总体而言,有证据表明他汀类药物治疗与 AAA 的改善之间存在关联。